Salvage Therapy in Recurrent Germ Cell Cancer
- 1 December 1991
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 5 (6) , 1211-1221
- https://doi.org/10.1016/s0889-8588(18)30379-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.Journal of Clinical Oncology, 1988
- Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsThe American Journal of Medicine, 1985
- Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiolsZeitschrift für Krebsforschung und Klinische Onkologie, 1984
- The oxazaphosphorinesCancer Treatment Reviews, 1983
- TEST OF FALSE-POSITIVE TESTICULAR CANCER MARKER BY SUPPRESSING LUTEINISING HORMONE WITH TESTOSTERONEThe Lancet, 1982
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow supportPublished by Elsevier ,1981
- Autologous Nonfrozen Bone Marrow Transplantation after Intensive Chemotherapy: A Pilot StudyActa Haematologica, 1981